由DNA甲基转移酶表观遗传修饰的AP-2α通过上调PD-L1表达来促进质瘤免疫逃避
Shengwen Long1, Guixiang Huang1,2, Mi Ouyang1
1The National & Local Joint Engineering Laboratory of Animal Peptide Drug Development, College of Life Science, Hunan Normal University, Changsha, 410081, China.
Cell death & disease
|June 17, 2023
概括
低AP-2α表达在质瘤增加PD-L1,促进免疫逃避. 重新激活AP-2α可增强T细胞免疫力和抗PD-1疗法的疗效,为固体瘤提供了一种新的策略.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 编程死亡配体1 (PD-L1) 促进瘤免疫逃逸,但其在质母细胞瘤中的调节知之甚少.
- 质瘤表现出较低的免疫反应和对治疗的耐药性,需要对PD-L1调节进行研究.
- 低AP-2α表达与高PD-L1水平在高度质瘤中相关.
研究的目的:
- 为了阐明PD-L1表达在质母细胞瘤中的调节机制.
- 研究AP-2α在调节抗瘤免疫力的作用.
- 探索结合AP-2α再激活与免疫治疗的治疗策略.
主要方法:
- 在质瘤组织中分析AP-2α和PD-L1表达.
- ChIP测试以确定AP-2α与CD274促进体结合.
- 在体外测试评估T细胞在AP-2α过度表达时的活性.
- 使用瘤免疫模型和组合治疗的体内研究.
主要成果:
- AP-2α直接抑制PD-L1转录,并促进其降解.
- 过度表达AP-2α增强了CD8+T细胞的增殖,细胞因子的分泌和细胞毒性.
- 通过EZH2 / H3K27Me3 / DNMT1复合物的表观遗传沉默保持了低的AP-2α水平.
- 结合Decitabine (5-Aza-dC) 和抗PD-1疗法抑制了GL261质瘤的进展.
结论:
- 对AP-2α的表观遗传沉默有助于质母细胞瘤免疫逃避.
- AP-2α的重新激活与抗PD-1抗体协同作用,以增强抗瘤免疫力.
- 准AP-2α表观遗传调节是固体瘤的一个有前途的治疗策略.
更多相关视频
11:19Correlating Gene-specific DNA Methylation Changes with Expression and Transcriptional Activity of Astrocytic KCNJ10 Kir4.1
Published on: September 26, 2015
8.0K
09:40Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
5.7K
相关概念视频
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Epigenetic Regulation
3.1K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.1K
Chromatin Modification in iPS Cells
1.7K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
1.7K
The Intrinsic Apoptotic Pathway
6.6K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.6K
